Patients with indicators of high-risk or established ASCVD, chronic kidney disease, or heart failure According to the ADA, when considering an agent for add-on to metformin background therapy, the first recommended consideration is whether or not the patient has indicators of high-risk or established ASCVD, chronic kidney disease (CKD), or heart failure ( Figure 2 )
In response, Felix Health (and almost certainly other telehealth providers in the coming weeks) launched a waitlist page inviting patients to register for updates when generic supply reaches their dispensaries
FDA-Labeled Indications for Chronic Weight Management As of early 2026, two medications carry FDA indications specifically for chronic weight management in adults: Wegovy (semaglutide 2.4 mg) approved 2021 Zepbound (tirzepatide) approved 2023 Liraglutide (Saxenda) is also approved for weight management but has been largely supplanted by the once-weekly options
At the same time, previous approvals can still be helpful because they provide precedent and can make it easier to justify the safety of a biomaterial in a new context
Weight loss injections in Maryland and Delaware are a very convenient way to help lose weight Phentermine Phentermine Mechanism of Action: Phentermine is a sympathomimetic amine that suppresses appetite by stimulating the release of norepinephrine in the brain
